Allworth Financial’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1K | Buy |
1,337
+1,121
| +519% | +$19.4K | ﹤0.01% | 2423 |
|
|
2025
Q1 | $3.79K | Buy |
216
+14
| +7% | +$246 | ﹤0.01% | 2902 |
|
|
2024
Q4 | $6.14K | Buy |
202
+95
| +89% | +$2.89K | ﹤0.01% | 2657 |
|
|
2024
Q3 | $3.09K | Buy |
107
+62
| +138% | +$1.79K | ﹤0.01% | 2770 |
|
|
2024
Q2 | $1.71K | Sell |
45
-290
| -87% | -$11K | ﹤0.01% | 2989 |
|
|
2024
Q1 | $19.7K | Sell |
335
-23
| -6% | -$1.35K | ﹤0.01% | 1784 |
|
|
2023
Q4 | $21.4K | Buy |
358
+260
| +265% | +$15.6K | ﹤0.01% | 1608 |
|
|
2023
Q3 | $3.73K | Buy |
98
+63
| +180% | +$2.4K | ﹤0.01% | 2255 |
|
|
2023
Q2 | $3.19K | Buy |
35
+14
| +67% | +$1.28K | ﹤0.01% | 2297 |
|
|
2023
Q1 | $1.39K | Sell |
21
-29
| -58% | -$1.91K | ﹤0.01% | 2547 |
|
|
2022
Q4 | $2.59K | Buy |
50
+3
| +6% | +$155 | ﹤0.01% | 2143 |
|
|
2022
Q3 | $3K | Buy |
47
+32
| +213% | +$2.04K | ﹤0.01% | 2000 |
|
|
2022
Q2 | $1K | Buy |
15
+11
| +275% | +$733 | ﹤0.01% | 2079 |
|
|
2022
Q1 | $0 | Sell |
4
-200
| -98% | – | ﹤0.01% | 2094 |
|
|
2021
Q4 | $10K | Buy |
+204
| New | +$10K | ﹤0.01% | 1370 |
|